Homepage600535 • SHA
add
Tasly Pharmaceutical Group Co Ltd
Vorige slotkoers
¥ 15,89
Dag-range
¥ 15,83 - ¥ 15,94
Jaar-range
¥ 12,38 - ¥ 17,77
Beurswaarde
23,68Â mld. CNY
Gem. volume
12,55Â mln.
Koers/winst
24,36
Dividendrendement
3,34%
Primaire beurs
SHA
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(CNY) | mrt 2025info | Wijziging j-o-j |
---|---|---|
Opbrengst | 2,05Â mld. | 0,30% |
Bedrijfskosten | 1,03Â mld. | 4,97% |
Netto inkomsten | 314,31Â mln. | 6,47% |
Netto winstmarge | 15,30 | 6,18% |
Winst per aandeel | — | — |
EBITDA | 437,65Â mln. | -15,96% |
Effectief belastingtarief | 18,60% | — |
Balans
Totale activa
Totale passiva
(CNY) | mrt 2025info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 2,93Â mld. | -39,70% |
Totale activa | 15,00Â mld. | -14,39% |
Totale passiva | 2,85Â mld. | -37,20% |
Totaal aandelenvermogen | 12,15 mld. | — |
Uitstaande aandelen | 1,49 mld. | — |
Koers-boekwaardeverhouding | 1,99 | — |
Rendement op activa | 5,65% | — |
Rendement op kapitaal | 6,23% | — |
Kasstroom
Nettomutatie in liquide middelen
(CNY) | mrt 2025info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | 314,31Â mln. | 6,47% |
Operationele kasstroom | -362,37Â mln. | -7,56% |
Kasstroom uit beleggingen | -48,08Â mln. | 83,74% |
Kasstroom uit financiering | 332,28Â mln. | -51,64% |
Nettomutatie in liquide middelen | -78,33Â mln. | -243,30% |
Vrije kasstroom | -200,50Â mln. | -684,20% |
Over
Tasly is a Chinese pharmaceutical company based in the city of Tianjin. It was established in 1994 and is notably producing traditional Chinese medicines.
It has a turnover of 4 billion US dollars, 10,000 employees and is listed on the Shanghai Stock Exchange.
In 2009, Chinese pharmacologist Li Lianda claimed that a key product made by Tasly was unsafe. Tasly sued Li in 2013, alleging that Li's claim was baseless and was motivated by his financial and employment relations with Guangzhou Pharmaceutical, a direct competitor of Tasly. In September 2014, the Tianjin High People's Court ruled in favour of Tasly and ordered Li to issue an apology and pay Tasly 300,000 yuan in compensation.
In February 2017, Tasly announced plans to form a joint venture with American multi-level marketing company Herbalife. Wikipedia
Opgericht
1994
Website
Werknemers
10.958